baber/WOPTO huggingface dataset:
Patent AU-6954094-A (AU)
Title: Lateral illumination fiber optic cable device and method of manufacture
Inventor: KINGSTONE BRETT M
IPC: B29C48/00
Filed: 1994-05-20
Abstract: A fiber optic cable (10) suitable for lateral illumination lighting installations has a tubular central core (12), wrapped perimetrically with angularly evenly distributed bundles (15) of optical fibers (16) and covered with a transparent sheath (17). The core includes an outer cylindrical surface (14) of reflective material (24) that deflects inwardly directed lateral emissions back outwardly, so they can contribute usefully to the visible light. In manufacture, the bundles are wound about the core by a cabling machine which simultaneously extrudes the sheath about the winding. In a modified embodiment, a cable (10') includes an arcuate cutout (30) that mates with a complementary track (39, 40) of a mounting strip (35) . Strip (35) includes a reflective substance in an area (38) between upper and lower cables (10') to present a continuous, top to bottom lateral illumination effect. In another form of the modified embodiment, the fiber bundles are provided directly within upper and lower reflective channels (41) formed integrally within the mounting strip.
Patent AU-6970187-A (AU)
Title: Metal ion labeling of carrier molecules
Inventor: NICOLOTTI ROBERT A
IPC: G01N33/532
Filed: 1987-03-04
Abstract: A conjugate of a protein or polypeptide and a metal ion is prepared by reacting a metal ion transfer complex comprising a chelate of 4,5-dihydroxyl-m-benzenedisulfonic acid or a salt thereof with a protein or polypeptide that is covalently bound to an exogenous chelating group having a greater affinity than 4,5-dihydroxyl-m-benzenedisulfonic acid for the metal ion.
Patent AU-7046591-A (AU)
Title: Method and apparatus for reclaiming gypsum from waste wallboard
Inventor: MACLEOD BRUCE COLIN
IPC: B29C63/00
Filed: 1991-01-08
Abstract: PCT No. PCT/CA91/00006 Sec. 371 Date Jan. 21, 1993 Sec. 102(e) Date Jan. 21, 1993 PCT Filed Jan. 8, 1991 PCT Pub. No. WO92/00152 PCT Pub. Date Jan. 9, 1992.This invention pertains to a method and apparatus for reclaiming gypsum from waste paper laminated gypsum wallboard. The invention is directed to an apparatus that is useful for separating paper laminate from gypsum wallboard comprising: a roller and a plate spatially disposed from the roller. The aperture between the roller and the plate is sized to be slightly less than the wallboard thickness thereby creating a fracturing action between the gypsum and the paper laminate. The first roller can be driven by a power source. A roller can be substituted for the plate and can be undriven or driven independently of the first roller.
Patent AU-7055198-A (AU)
Title: Coded electronic lock for doors and windows
Inventor: GODOY ALAIN
IPC: E05B17/20
Filed: 1998-04-03
Abstract: Disclosed is a cordless electronic lock with a variable "automatic" code, having at least one main bolt (4) operated by an electric motor (M), and controlled by an electronic circuit. A storage cell (A) integrated into the lock is used to supply the elements with electricity; said storage cell can itself be supplied with power from an external source (if necessary). A remote control transmits a coded signal (encoded list) to which the transmission code automatically adapts. The receiver verifies (on its own list) the codes received, and "activates the motor". the lock is thus comprised of at least the following elements: one transmitter unit (key); a receiver; a circuit for controlling the motor; a motor; a bolt mechanism; and a regulated and protected supply circuit. All the elements are contained in a main shielded casing.
Patent AU-7112291-A (AU)
Title: Process for reducing halide ion content of poly(vinylbenzyl ethers) of polyphenols
IPC: C07C41/16
Filed: 1991-02-18
Abstract: Poly(vinylbenzyl ethers) of polyphenols are prepared by reacting an alkali metal, alkaline earth metal, or ammonium salt of a polyphenol with a vinylbenzyl halide in a liquid reaction medium consisting essentially of a monohydric alcohol or glycol having from 1 to 11 carbon atoms, a polyglycol having a weight average molecular weight ranging from 200 to 4000, or glycerol. Halide ion content of poly(vinylbenzyl ethers) of polyphenols prepared by the method of this invention and other methods are reduced by dissolving the ether in a solvent that dissolves no more than 1.0 weight percent of an alkali metal, alkaline earth metal, or ammonium halide; separating the ether solution from the halide salt; and then recovering the ether from the solution.
Patent AU-7140794-A (AU)
Title: Intermediates useful in the preparation of 2-tetrahydrofuranderivatives
Inventor: ESTERMANN HEINRICH
IPC: A61P37/00
Filed: 1994-08-23
Abstract: The compound of formula I <CHEM> and its enantiomer with the (S) configuration can be prepared by appropriate substitution, protection and/or deprotection from the compound of formula II <CHEM> which itself can be prepared by enantiospecific monohydrolysis of 2,2-bis(hydroxymethyl)tetrahydrofuran dibutyrate. They have unusual pharmacological activity: the compound of formula I has activity in treating multiple sclerosis and its enantiomer in treating tumors. The compound of formula II and its protected forms are useful intermediates for preparing further optically pure pharmacologically active compounds having an asymmetrically substituted carbon atom adjacent to the oxygen atom in a tetrahydrofuran ring.
Patent AU-7305501-A (AU)
Title: Sample processing devices
Inventor: BEDINGHAM WILLIAM
IPC: B01L9/00
Filed: 2001-06-28
Abstract: Methods and devices for thermal processing of multiple samples at the same time are disclosed. The assemblies include carriers and sample processing devices with process arrays that include conduits useful in distributing sample materials to a group of process chambers located in fluid communication with the main conduits. The sample processing devices may include one or more of the following features in various combinations: deformable seals, process chambers connected to the main conduit by feeder conduits exciting the main conduit at offset locations, U-shaped loading chambers, and a combination of melt bonded and adhesively bonded areas. The carriers may be used to apply selective compression to the sample processing devices.
Patent AU-7465300-A (AU)
Title: Powder composition comprising aggregates of iron powder and additives and a flow agent and a process for its preparation
Inventor: ARVIDSSON JOHAN
IPC: B22F3/02
Filed: 2000-09-07
Abstract: The present invention concerns powder compositions including iron-containing powders, additives, lubricant and flow agents. The powder compositions essentially consist of iron-containing particles having additive particles bonded thereto by a molten and subsequently solidified lubricant for the formation of aggregate particles and from about 0.005 to about 2 percent by weight of a flow agent having a particle size below 200 nanometers.
Patent AU-7474896-A (AU)
Title: Custom-molded ankle brace
Inventor: PARKER BRUCE A
IPC: A61F5/01
Filed: 1996-10-25
Abstract: An ankle brace product including an ankle brace for being custom-formed to the shape of an ankle while flexible and upon hardening providing a rigid, supporting custom fit. The ankle brace product includes an outer container formed of moisture-impervious material and a flexible ankle brace positioned in the container in substantially moisture-free conditions and sealed therein against entry of moisture until use. The ankle brace includes an elongate substrate with a reactive system impregnated into or coated onto the substrate. The system remains stable when maintained in substantially moisture-free conditions and hardens upon exposure to moisture to form a rigid, self supporting structure. An elongate, flexible protective pad is positioned on one side of the substrate along its length to provide a cushioning barrier between the substrate and the skin of a patient when the ankle brace is in use. An outer wrapping encloses the substrate and the protective pad. Alternatively, the outer wrapping covers the substrate and the pad provides protection on the other side of the brace next to the skin. The substrate, protective pad and outer wrapping define a first brace segment for being molded while flexible to the lateral aspect of the foot, ankle and lower leg, a second brace segment for being molded to the medial aspect of the foot, ankle and lower leg, and a heel support of reduced width in comparison with the first and second brace segments for supporting the heel and the molded first and second segments.
Patent AU-7522296-A (AU)
Title: Staggered stream support for video on demand
Inventor: VAHALIA URESH K
IPC: H04N7/173
Filed: 1996-10-28
Abstract: A video file server includes an integrated cached disk array storage subsystem and a plurality of stream server computers linking the cached disk storage subsystem to a data network for the transfer of video data streams. The video file server further includes a server controller for applying an admission control policy to client requests and assigning stream servers to service the client requests. The stream servers include a real-time scheduler for scheduling isochronous tasks, and supports at least one industry standard network file access protocol and one file access protocol for continuous media file access. The cached disk storage subsystem is responsive to video prefetch commands, and the data specified for a prefetch command for a process are retained in an allocated portion of the cache memory from the time that the cached disk storage subsystem has responded to the prefetch command to the time that the cached disk storage subsystem responds to a fetch command specifying the data for the process. The time between prefetching and fetching is selected based on available disk and cache resources. The video file server provides video-on-demand service by maintaining and dynamically allocating sliding windows of video data in the random access memories of the stream server computers.
Patent AU-7762794-A (AU)
Title: Process of preparing etoposide phosphate and etoposide
Inventor: SILVERBERG LEE J
IPC: A61P35/00
Filed: 1994-11-03
Abstract: Etoposide phosphate is prepared by coupling dibenzyl 4'-demethyl-4-epipodophyllotoxin-4'-phosphate with 2,3-di-O-benzyl-4,6-O-ethylene- alpha , beta -D-glucopyranose in a solvent and subsequently removing the protecting groups. The tetra-benzyl protected etoposide phosphate is recrystallized from methanol or directly crystallized from acetonitrile by adding methanol to yield substantially the pure C-1''- beta  form. The benzyl protecting groups are simultaneously removed by hydrogenation to produce etoposide phosphate in high yields. In a further embodiment, etoposide phosphate is treated with a phosphatase enzyme to yield etoposide.
Patent AU-7859791-A (AU)
Title: Interleukin-4 binding protein-gamma
Inventor: FANSLOW WILLIAM C
IPC: C07K16/28
Filed: 1991-03-29
Abstract: Isolated and purified Interleukin-4 Binding Protein- gamma  (IL-4bp gamma ) and methods for obtaining isolated and purified IL-4bp gamma .
Patent AU-7945098-A (AU)
Title: Iron-based metallurgical compositions containing flow agents and methods for using same
Inventor: LUK SYDNEY
IPC: C22C33/02
Filed: 1998-05-15
Abstract: The present invention concerns an improved metallurgical powder composition comprising a major amount of an iron based metal powder and a minor amount of a particulate inorganic oxide having an average particle size below 500 nm.
Patent AU-7986994-A (AU)
Title: Alkyd paints
Inventor: BRAEKEN JOSEF
IPC: C09D167/08
Filed: 1994-10-28
Abstract: High-solids air-drying or semi-drying alkyd paints essentially comprise, as binder, a conventional air-drying or semi-drying long-oil or medium-oil alkyd resin, and as reactive diluent an oligomer of polyol, polyisocyanate and unsaturated fatty acids. Use of the oligomer as reactive diluent is also claimed.
Patent AU-8341298-A (AU)
Title: Reducing message traffic in intelligent network
Inventor: TUUNANEN HEIKKI
IPC: H04M3/00
Filed: 1998-07-08
Abstract: A method of reducing message traffic between a service control point and a switching point for executing an intelligent network service in the service switching point. A service logic comprising the operations the execution of which implements said intelligent network service is formed for each intelligent network service to be executed in the switching point. The service switching point receives the service logic, and at lest one criterion, upon the fulfillment of which the service switching point is to execute said operations. Upon fulfillment of said criterion, the service switching point executes said operations.
Patent AU-8562498-A (AU)
Title: Amine derivatives
Inventor: YUASA MASAYUKI
IPC: C07C223/02
Filed: 1998-08-11
Abstract: The present invention relates to amine derivatives represented by formula (1) or salts thereof. <CHEM>  (wherein R<1> is C1-C4 alkyl; R<2> is <CHEM>   <CHEM>  or <CHEM> R<3> represents C1-C3 alkyl, hydroxylated C1-C5 alkyl, C1-C5 acyl; C2-C5 alkenyl, or a halogen atom; and k, l, and m are each an integer of 1 to 4.) Exhibiting excellent antifungal effect, these compounds are highly useful as antifungal agents, antifungal compositions, drugs, etc.
Patent AU-8641698-A (AU)
Title: A cermet having a binder with improved plasticity, a method for the manufacture and use therof
Inventor: HEINRICH HANS-WILM
IPC: C22C19/07
Filed: 1998-08-20
Abstract: Cermets having a Co-Ni-Fe-binder are described. The Co-Ni-Fe-binder is unique in that even when subjected to plastic deformation, the binder substantially maintains its face centered cubic crystal structure and avoids stress and/or strain induced phase transformations. Stated differently, the Co-Ni-Fe-binder exhibits reduced work hardening.
Patent AU-8665991-A (AU)
Title: Antiviral compounds and antihypertensive compounds
Inventor: AFONSO ADRIANO
IPC: C07D311/06
Filed: 1991-09-06
Abstract: PCT No. PCT/US91/06252 Sec. 371 Date Mar. 1, 1993 Sec. 102(e) Date Mar. 1, 1993 PCT Filed Sep. 6, 1991 PCT Pub. No. WO92/04327 PCT Pub. Date Mar. 19, 1992.Compounds useful as antihypertensive agents and useful as antiviral agents against DNA-containing viruses, such as herpes group viruses, are disclosed. The compounds are represented by Formula 1.0:    <IMAGE>  (1.0)  and their pharmaceutically acceptable salts and solvates. Pharmaceutical compositions containing compounds represented by Formula 1.0 are disclosed. Methods of treating a viral infection using compounds represented by Formula 1.0 are disclosed. Also disclosed are methods of treating hypertension using compounds of Formula 1.0 wherein R is selected from the group consisting of H, halogen and -C(O)OR6; and R1 is selected from the group consisting of -OR14, -O(CH2)a C(H)3-iZi and -O(CH2)hN(R15)2.
Patent AU-8724191-A (AU)
Title: Isoparaffin alkylation processes using alumina catalysts
Inventor: COOPER MICHAEL D
IPC: B01J38/50
Filed: 1991-09-25
Abstract: This invention is a process for the alkylation of isoparaffin with olefins using a catalyst system comprising certain transition aluminas promoted with a Lewis acid (preferably BF3), and free Lewis acid. The product alkylate is a complex mixture of branched paraffins suitable for use as a high octane blending component for motor fuels.
Patent AU-8760791-A (AU)
Title: Regulation of immunoglobulin production by interleukin-9
Inventor: DUGAS BERNARD
IPC: A61K39/395
Filed: 1991-10-01
Abstract: A method for inhibiting production of IgE, and a method for enhancing production of IgG are taught. The methods are linked to the role of interleukin-9 in antibody production. Specifically, production of IgG is potentiated by administering either to a subject or a cell culture a combination of interleukin-4 and interleukin-9. Production of IgE is inhibited by administering an amount of an interleukin-9 inhibitor to a subject.
Patent AU-8978698-A (AU)
Title: Production of erythropoietin by endogenous gene activation
Inventor: STERN ANNE
IPC: C07K1/16
Filed: 1998-07-22
Abstract: The invention concerns human cells which, owing to the activation of the endogenous human erythropoietin gene, can produce erythropoietin (EPO) in sufficient quantities and degree of purity to allow human EPO to be economically produced as a pharmaceutical preparation. The invention also concerns a process for producing such human EPO-producing cells, DNA-constructs for activating the endogenous EPO gene in human cells and a process for the large-scale production of EPO in human cells.
Patent AU-9130891-A (AU)
Title: Device for injecting a gaseous fuel into an internal combustion engine, and also metering device and pressure regulating valve
Inventor: SCHMAL PETER
IPC: F16K3/32
Filed: 1991-12-19
Abstract: PCT No. PCT/NL91/00267 Sec. 371 Date Aug. 12, 1993 Sec. 102(e) Date Aug. 12, 1993 PCT Filed Dec. 19, 1991 PCT Pub. No. WO92/11448 PCT Pub. Date Jul. 9, 1992.Device for injecting a gaseous fuel into an internal combustion engine with several cylinders is provided with a vaporizer pressure regulator and metering elements for supplying the fuel from the vaporizer/pressure regulator to the inlet of the cylinders. In order to ensure a uniform supply to each cylinder, the metering elements have separate metering apertures, each of which belongs to its own cylinder, and which are connected by separate respective pipes to the cylinder. A pressure regulating valve is also provided in each pipe near the inlet of the cylinder, for the purpose of maintaining a constant pressure between the metering elements and the inlet.
Patent AU-9175501-A (AU)
Title: Therapeutic methods for treating subjects with a recombinant erythropoietin having high activity and reduced side effects
Inventor: THOMPSON LAWRENCE H
IPC: A61K33/24
Filed: 2001-08-09
Abstract: The invention discloses several novel therapeutic properties and methods of treatment using the recombinant erythropoietin prepared by expression from the Apa I restriction fragment of human genomic erythropoietin DNA transformed into baby hamster kidney cells (BHK) according to U.S. Patent No. 5,688,697 to Powell. This recombinant erythropoietin designated herein as Epoetin Omega is shown to possess several unexpected and superior qualities over other recombinant erythropoieteins such as those designated Epoetin Alfa and Beta which are prepared from genomic or cDNA expressed in Chinese Hamster Ovary (CHO) according to U.S. Patent Nos. 4,703,008 and 5,955,422 to Lin. The superior properties of Epoetin Omega include, but are not limited to, a much higher potency, a much more rapid response (i.e. no latency), longer effective serum levels, much lower antigenicity in human subjects, therapeutic activity in subjects non-responsive to the other epoetins, fewer adverse side effects such as incidents of thrombosis, reduced nausea, reduced pain at the site of injection, reduction in body pain, and most significantly, the absence of, or reduced risk of, increased blood pressure or hypertension. These novel properties provide for novel therapeutic methods including, treatment of anemia and treatment of conditions other than anemia such as fatigue or vascular pain, treatment in patients adversely effected by hypertension such as patients with heart conditions or at increased risk of thrombosis, treatment in oncology settings with and without chemotherapy or radiation therapy, and treatment with novel dosing regiments that include much lower doses and lower administration frequencies of as few as once per week or less.
Patent AU-9451498-A (AU)
Title: Coated aluminium workpiece
Inventor: BARLOW ERIC
IPC: C25D11/18
Filed: 1998-10-13
Abstract: Coating comprising adhesion promoter(s) excluding silane is applied to an aluminium work piece with an anodic oxide film surface. Preferred Features: The work piece is an aluminium sheet, and has a paint, lacquer, varnish or enamel layer over the adhesion promoter layer.
Patent BE-897607-A (BE)
Title: Nouveaux derives acyles de 1, 2, 4-triazole, leurs intermediaires, procede pour leurpreparation et compositions medicamenteuses contenant les derives de 1, 2, 4-triazole
IPC: A61K31/41
Filed: 1983-08-29
Abstract: Dérivs acyleés de 1,2,4-triazole de formule générale (I), dans laquelle : R1 représente un groupe phényle portant éventuellement un ou plusieurs substituants halogènes alkyle inférieur, alcoxy, acyloxy, hydroxy, amine, azide, nitro, trifluorométhyle, alkythio inférieur alkylsulfinyle, alkysulfonyle et R2 représente un groupe alkyle comportant de 1 à 6 atomes de carbone ou un groupe phénylalkyle contenant 1 à 4 atomes de carbone dans le fragment alkyle.
Patent BE-895434-A (BE)
Title: Cooling of moving thin steel strip - by low intensity and then high intensity cooling to avoid strip distortion
IPC: C21D9/573
Filed: 1982-12-21
Abstract: In the cooling of a moving thin metal strip by spraying coolant on the strip surface, the cooling comprises two phases; (a) a low intensity phase in which the heat transfer coefficient (measured at 600 deg.C) is max. 3kW/sq.m/deg.C; and (b) a high intensity phase in which the heat transfer coefficient is greater than 3kW/sq.m/deg.C. Pref. phase (a) is effected until a predetermined strip temp. (pref. 350-600 deg.C) is obtained and then phase (b) is effected. The process is esp. useful for cooling steel strip in continuous heat treatment lines. Intense cooling of the strip is obtained while maintaining strip flatness and avoiding stretcher strains.
Patent BE-749422-A (BE)
Title: 2-chloro-delta 1,4-steroids
IPC: B65D39/00
Filed: 1970-04-23
Abstract: 2-Chloro-DELTA1,4-steroids of formula : (where R1 is H or CH3; R2 is H, free or esterified OH; X is F, Cl or CH3; Y is H or halogen; Z is halogen of atomic wt. = Y, OH in beta-posn. or when Y is H, Z is an OH in alpha-posn.). A prefd. cpd. is 6alpha-fluoro-1alpha,2beta-dichloro-11beta-hydroxy-21-acetoxy-16a- lpha-methyl-4-pregnene-3,20-dione. Cpds. useful as anti-inflammatories.
Patent BE-756229-A (BE)
Title: Polyacrylate modifier for polyvinyl chlori- - de
IPC: C08F259/04
Abstract: PVC adduct comprises (1) producing PVC particles by suspension polymerisn. of vinyl chloride monomer in the presence of an emulsifier (2) removal of unreacted monomer, (3) addn. of a chain transfer agent and a soln. (a) of a acrylate ester monomer comprising 80-100 wt. % methyl methacrylate and 20-0 wt. % other monomers, and (b) an effective amt. of at least 1 free radical catalyst initiator which is sol. in the monomer (a). (4) The mixture is polymerised with agitation and the polyacrylate modified PVC particles are recovered.
Patent BR-0002251-A (BR)
Title: Revestimentos de organopolissiloxano curáveis em baixa temperatura
Inventor: LEWIS LARRY NEIL
IPC: D21H19/32
Filed: 2000-04-26
Abstract: Patente de Invenção: <B>"REVESTIMENTOS DE ORGANOPOLISSILOXANO CURáVEIS EM BAIXA TEMPERATURA"<D>. Método de fabricação de um substrato revestido que inclui as etapas de aplicar uma camada de uma composição de revestimento, a dita composição de revestimento compreendendo um alquenil organopolissiloxano funcional e um hidreto organopolissiloxano funcional, ao substrato, o dito substrato compreendendo uma quantidade cataliticamente eficaz de um catalisador de metal precioso, e permitir que a camada cure, permitir o uso de um banho de revestimento não-catalisado tendo uma vida útil bastante longa, enquanto provendo um camada de revestimento altamente reativa que pode ser rapidamente curada em baixa temperatura.